WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
Machine translation
8. (WO2012135526) VOXEL-RESOLUTION MYOCARDIAL BLOOD FLOW ANALYSIS
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

What is claimed is:

1. A method for estimating myocardial blood flow, the method comprising:

a processing device applying a pharmacological kinetic model to a data set stored in a storage device, the data set derived from an imaging technique based on monitoring fluid based tracers in a left ventricle, a right ventricle, and myocardium, wherein the pharmacological kinetic model includes:

incorporating a model of changing concentrations of bound fluid based tracers, unbound fluid based tracers, and blood plasma fluid based tracers into a standard factor analysis of dynamic structures model combined with a model of fluid based tracer activity in the left ventricle as a time shifted and dispersed function of blood flow from the right ventricle;

the processing device outputting a processed data set based on the application of the

pharmacological kinetic model to the data set for providing a representation of blood flow in the myocardium.

2. The method of claim 1 further comprising the processing device estimating parameters of the standard factor analysis of dynamic structures model by applying a penalty term to account for time activity curves for the right ventricle imaging activity from the fluid based tracers and the left ventricle imaging activity from the fluid based tracers decaying to zero over time.

3. The method of claim 1 further comprising the processing device estimating parameters of the standard factor analysis of dynamic structures model by estimating maximum values of fluid based tracer activity in one or both of the right ventricle or the left ventricle and modifying a corresponding signal vector value for the one of the right ventricle or the left ventricle using the estimated maximum values of fluid based tracer activity.

4. The method of claim 1 further comprising the processing device estimating parameters of the standard factor analysis of dynamic structures model by:

estimating a left ventricle tissue activity curve, a right ventricle tissue activity curve, and a tissue activity curve, wherein the left ventricle tissue activity curve is assumed to be approximately equal to a response of an mth-order, all-pole filter applied to the right ventricle tissue activity curve, and

determining a set of parameters that produce a smallest least-squares error for the pharmacological kinetic model.

5. The method of claim 4 wherein the estimating further comprises for a given initial estimate right ventricle tissue activity curve and a given initial estimated left ventricle tissue activity curve, determining initial estimates for parameters of the pharmacological kinetic model.

6. A non-transitory computer readable medium storing instructions that cause a processing device, in response to executing the instructions, to perform operations comprising:

the processing device applying a pharmacological kinetic model to a data set stored in a storage device, the data set derived from an imaging technique based on monitoring fluid based tracers in a left ventricle, a right ventricle, and myocardium, wherein the pharmacological kinetic model includes:

incorporating a model of changing concentrations of bound fluid based tracers, unbound fluid based tracers, and blood plasma fluid based tracers into a standard factor analysis of dynamic structures model combined with a model of fluid based tracer activity in the left ventricle as a time shifted and dispersed function of blood flow from the right ventricle;

the processing device outputting a processed data set based on the application of the

pharmacological kinetic model to the data set for providing a representation of blood flow in the myocardium.

7. The non-transitory computer readable medium of claim 6 further comprising instructions to cause the processing device to perform operations comprising estimating parameters of the standard factor analysis of dynamic structures model by applying a penalty term to account for time activity curves for the right ventricle imaging activity from the fluid based tracers and the left ventricle imaging activity from the fluid based tracers decaying to zero over time.

8. The non-transitory computer readable medium of claim 6 further comprising instructions to cause the processing device to perform operations comprising estimating

parameters of the standard factor analysis of dynamic structures model by estimating maximum values of fluid based tracer activity in one or both of the right ventricle or the left ventricle and modifying a corresponding signal vector value for the one of the right ventricle or the left ventricle using the estimated maximum values of fluid based tracer activity.

9. The non-transitory computer readable medium of claim 6 further comprising instructions to cause the processing device to perform operations comprising estimating parameters of the standard factor analysis of dynamic structures model by:

estimating a left ventricle tissue activity curve, a right ventricle tissue activity curve, and a tissue activity curve, wherein the left ventricle tissue activity curve is assumed to be approximately equal to a response of an mth-order, all-pole filter applied to the right ventricle tissue activity curve, and

determining a set of parameters that produce a smallest least-squares error for the

pharmacological kinetic model.

10. The non-transitory computer readable medium of claim 9 further comprising instructions to cause the processing device to perform operations comprising for a given initial estimate right ventricle tissue activity curve and a given initial estimated left ventricle tissue activity curve, determining initial estimates for parameters of the pharmacological kinetic model.

11. An apparatus comprising:

a processing device configured to apply a pharmacological kinetic model to a data set stored in a storage device, the data set derived from an imaging technique based on monitoring fluid based tracers in a left ventricle, a right ventricle, and myocardium, wherein the pharmacological kinetic model includes:

incorporating a model of changing concentrations of bound fluid based tracers, unbound fluid based tracers, and blood plasma fluid based tracers into a standard factor analysis of dynamic structures model combined with a model of fluid based tracer activity in the left ventricle as a time shifted and dispersed function of blood flow from the right ventricle;

the processing device configured to output a processed data set based on the application of the pharmacological kinetic model to the data set for providing a representation of blood

flow in the myocardium.

12. The apparatus of claim 11 wherein the processing device is configured to estimate parameters of the standard factor analysis of dynamic structures model by applying a penalty term to account for time activity curves for the right ventricle imaging activity from the fluid based tracers and the left ventricle imaging activity from the fluid based tracers decaying to zero over time.

13. The apparatus of claim 11 wherein the processing device is configured to estimate parameters of the standard factor analysis of dynamic structures model by estimating maximum values of fluid based tracer activity in one or both of the right ventricle or the left ventricle and modifying a corresponding signal vector value for the one of the right ventricle or the left ventricle using the estimated maximum values of fluid based tracer activity.

14. The apparatus of claim 11 wherein the processing device is configured to estimate parameters of the standard factor analysis of dynamic structures model by:

estimating a left ventricle tissue activity curve, a right ventricle tissue activity curve, and a tissue activity curve, wherein the left ventricle tissue activity curve is assumed to be approximately equal to a response of an mth-order, all-pole filter applied to the right ventricle tissue activity curve, and

determining a set of parameters that produce a smallest least-squares error for the

pharmacological kinetic model.

15. The apparatus of claim 14 wherein the estimating further comprises for a given initial estimate right ventricle tissue activity curve and a given initial estimated left ventricle tissue activity curve, determining initial estimates for parameters of the pharmacological kinetic model.